Tag: Rhythm Pharmaceuticals

LG Chem, Rhythm ink $305 million tech transfer deal for obesity treatment

LG Chem has inked a technology transfer deal worth up to $305 million with Boston’s Rhythm Pharmaceuticals for its oral obesity treatment candidate.